Search Result "antitopoisomerase I"
Recent Advances in the Development of Dual Topoisomerase I and II Inhibitors as Anticancer Drugs
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 3 Year: 2010 Page: 4270-4290
Author(s): S. Salerno, F. Da Settimo, S. Taliani, F. Simorini, C. La Motta, G. Fornaciari, A. M. Marini
A SAR Study: Evaluation of Bromo Derivatives of 8-Substituted Quinolines as Novel Anticancer Agents
Journal: Letters in Drug Design & Discovery
Volume: 14 Issue: 1 Year: 2017 Page: 1415-1424
Author(s): Salih Okten, Osman Cakmak, Saban Tekin, Tugba Kul Koprulu
Anticancer and Cytotoxic Activities of [Cu(C6H16N2O2)2][Ni(CN)4] and [Cu(C6H16N2O2)Pd(CN)4] Cyanidometallate Compounds on HT29, HeLa, C6 and Vero Cell Lines
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 6 Year: 2017 Page: 865-874
Author(s): Ali Aydın,Sengul Aslan Korkmaz,Veysel Demir,Saban Tekin
From Raynaudâs Phenomenon to Very Early Diagnosis of Systemic Sclerosis- The VEDOSS approach
Journal: Current Rheumatology Reviews
Volume: 9 Issue: 4 Year: 2013 Page: 245-248
Author(s): Silvia Bellando-Randone,Marco Matucci-Cerinic
1,3,4-Oxadiazoles as Potential Pharmacophore for Cytotoxic Potentiality: A Comprehensive Review
Journal: Current Topics in Medicinal Chemistry
Volume: 21 Issue: 15 Year: 2021 Page: 1377-1397
Author(s): Divya Sharma,Salahuddin,Vikas Sharma,Rajnish Kumar,Sagar Joshi,Sunita Kumari,Shivani Saxena,Avijit Mazumder,Mohammad Shahar Yar,Mohamed Jawed Ahsan
Cardiovascular Magnetic Resonance Imaging clarifies cardiac pathophysiology in early, asymptomatic diffuse systemic sclerosis
Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 14 Issue: 1 Year: 2015 Page: 29-36
Author(s): Sophie I. Mavrogeni,Konstantinos Bratis,Georgia Karabela,George Spiliotis,Kees van Wijk,David Hautemann,Johan H.C. Reiber,Loukia Koutsogeorgopoulou,George Markousis-Mavrogenis,Genovefa Kolovou,Efthymios Stavropoulos
Imidazolidine Derivatives in Cancer Research: What is known?
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 7 Year: 2022 Page: 1272-1277
Author(s): Auvani Antunes da Silva Júnior,Marina Galdino da Rocha Pitta,Mardonny Bruno de Oliveira Chagas,Moacyr Jesus Barreto de Melo Rêgo,Michelle Melgarejo da Rosa,Maira Galdino da Rocha Pitta
Exploiting EPR in Polymer Drug Conjugate Delivery for Tumor Targeting
Journal: Current Pharmaceutical Design
Volume: 12 Issue: 3 Year: 2006 Page: 4785-4796
Author(s): Sweta Modi, Jay Prakash Jain, A. J. Domb, Neeraj Kumar
Endothelin Receptor Antagonists as Disease Modifiers in Systemic Sclerosis
Journal: Inflammation & Allergy - Drug Targets (Discontinued)
Volume: 10 Issue: 1 Year: 2011 Page: 19-26
Author(s): Nagalakshmi Shetty, Chris T. Derk
Recent Development in the Search for Epidermal Growth FactorReceptor (EGFR) Inhibitors based on the Indole Pharmacophore
Journal: Current Topics in Medicinal Chemistry
Volume: 24 Issue: 7 Year: 2024 Page: 581-613
Author(s):